Lawmakers Fight FDA's Anti-Estriol Stance
In the wake of the U.S. Food and Drug Administration's backlash against bioidentical hormone replacement drugs, lawmakers introduced a resolution Tuesday opposing the agency's policy restricting women's access to the products....To view the full article, register now.
Already a subscriber? Click here to view full article